A standard vector for the chromosomal integration and characterization of BioBrick™ parts in Escherichia coli by Susanna Zucca et al.
Zucca et al. Journal of Biological Engineering 2013, 7:12
http://www.jbioleng.org/content/7/1/12RESEARCH Open AccessA standard vector for the chromosomal
integration and characterization of BioBrick™
parts in Escherichia coli
Susanna Zucca1,2, Lorenzo Pasotti1,2, Nicolò Politi1,2, Maria Gabriella Cusella De Angelis2 and Paolo Magni1,2*Abstract
Background: The chromosomal integration of biological parts in the host genome enables the engineering of
plasmid-free stable strains with single-copy insertions of the desired gene networks. Although different integrative
vectors were proposed, no standard pre-assembled genetic tool is available to carry out this task. Synthetic biology
concepts can contribute to the development of standardized and user friendly solutions to easily produce
engineered strains and to rapidly characterize the desired genetic parts in single-copy context.
Results: In this work we report the design of a novel integrative vector that allows the genomic integration of
biological parts compatible with the RFC10, RFC23 and RFC12 BioBrick™ standards in Escherichia coli. It can also be
specialized by using BioBrick™ parts to target the desired integration site in the host genome. The usefulness of
this vector has been demonstrated by integrating a set of BioBrick™ devices in two different loci of the E. coli
chromosome and by characterizing their activity in single-copy. Construct stability has also been evaluated and
compared with plasmid-borne solutions.
Conclusions: Physical modularity of biological parts has been successfully applied to construct a ready-to-engineer
BioBrick™ vector, suitable for a stable chromosomal insertion of standard parts via the desired recombination
method, i.e. the bacteriophage integration mechanism or homologous recombination. In contrast with previously
proposed solutions, it is a pre-assembled vector containing properly-placed restriction sites for the direct transfer of
various formats of BioBrick™ parts. This vector can facilitate the characterization of parts avoiding copy number
artefacts and the construction of antibiotic resistance-free engineered microbes, suitable for industrial use.Background
Plasmids are extensively used tools to generate genetically
engineered microbes for the expression of recombinant
proteins or complex genetic circuits [1-4]. Even if they are
very easy to manipulate and incorporate in the desired
host, many disadvantages affect their use in both industrial
applications and research studies. Common plasmids
require the selective pressure of an antibiotic to be
maintained in cells, which is costly for industrial scale
recombinant protein production [5]. The spreading of
antibiotics and resistance markers is also potentially
unsafe for the environment [5] and some (e.g., ampicillin)* Correspondence: paolo.magni@unipv.it
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reproduction in any medium, provided the orshould be avoided in therapeutic protein production
because of the potential for human allergic reactions [6].
Selection systems without antibiotics are available, but
they require mutant host strains, specific growth media or
expensive reagents and in some cases they show low
efficiency [5,7]. Plasmids are often replicated in multiple
copy in the host cell, which enables the industrial production
of a large amount of protein [6]. However, plasmid-free
strains with the desired recombinant genes in single copy
are required in many studies, e.g., to investigate the effect
of these genes in normal physiological conditions, thus
avoiding copy-number artefacts [8]. Genome integration
can provide the stable insertion of the desired genes in the
host chromosome without the need of any antibiotic or
resistance marker. Several tools for Escherichia coli have
been proposed which exploit homologous or site-specific
recombination. Homologous recombination can betd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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passenger) into a specific genomic locus that must show
sufficient sequence homology with a second DNA
fragment (here called guide) used to target the locus [9].
This technology can also be used for gene knockout and
mutation of native genes [10]. Integrative plasmids (that
perform single- or double-crossover) [11], linear PCR
fragments [12] and also single-stranded DNA [13] perform
the described tasks by means of unspecific endogenous or
heterologous protein machinery (e.g., the λRed system
[12,13]). On the other hand, site-specific recombination
uses genome insertion of bacteriophages in the host
chromosome through the phage attachment site (attP) and
the bacterial attachment site (attB) sequences [14]. This
mechanism has been exploited to develop integrative
vectors carrying the attP site (guide) and the passenger
[15]. The gene expression machinery that mediates
homologous or site-specific recombination can be placed
on an easily curable helper plasmid transformed in the
host strain [9,15]. Figure 1 illustrates how homologous
recombination (with a single-crossover event) and
site-specific recombination work.
Generally, integrant clones are selected with an antibiotic
resistance marker. This marker can be removed by
exploiting FRT sites: by flanking a sequence with FRT
sites, it can be targeted for excision through the yeast
Flp recombinase. Helper plasmids expressing the Flp
recombinase have also been constructed [16].Figure 1 Main plasmid-based methodologies for chromosomal integr
integrative plasmid (green) carries a sequence (red) that is homologous wi
crossover event, mediated by the endogenous recombination machinery o
of the chromosome. In specific recA-knockout strains the recombination m
recombination. The integrative plasmid carries a bacteriophage attachmen
site (attB) in the host genome. This process is mediated by a specific recom
sites are composed by the POP’ and BOB’ sequences, respectively. They sha
(P, P’, B and B’), so that after site-specific recombination the integrated plas
specific att sequences have this common structure. In both homologous a
via antibiotic resistance, provided that the integrative plasmid sequence coIntegrative plasmids must be easily amplified in vivo,
and clones with a successful integration must be easily
selected. To this aim, conditional-replication origins are
exploited. They support plasmid replication only in specific
conditions, like a specific strain or a temperature range,
while the plasmid becomes non-replicative otherwise [10].
For example, the R6K replication origin can be used to
propagate integrative plasmids only when the pir or
pir-116 gene is present in the host strain [15].
Recent advances in the field of synthetic biology include
the standardization of biological parts to facilitate the
assembly of genetic circuits [17]. BioBrick™ parts in the
Registry of Standard Biological Parts are a rapidly-growing
collection of DNA parts that conform to a specific
physical standard [18]. BioBrick™-compatible genetic
circuits can be easily incorporated in a microbial host
through ad-hoc constructed BioBrick™ plasmids [19].
Although the construction of integrative systems by using
BioBrick™ parts has been reported [20], no standard and
ready-to-use solution is available to produce engineered
strains with BioBrick™ parts via chromosomal integration.
In fact, current tools for site-directed genome integration
via integrative vectors include either non-BioBrick™
plasmid vectors with specific, non-customizable DNA
guide [15] or BioBrick™-compatible parts [20] that can
be used to compose integrative vectors via a standard
assembly procedure, but a pre-assembled ready-to-use
solution is not available.ation of parts in E. coli. A) Homologous recombination. The
th a region (red) in the bacterial chromosome (blue). After a single-
f E. coli, the whole plasmid sequence is integrated in the target region
achinery can be expressed via a helper plasmid. B) Site-specific
t site (attP) that targets the whole plasmid into the specific attachment
binase that can be expressed via a helper plasmid. The attP and attB
re a homologous core sequence (O) and different flanking sequences
mid is flanked by the BOP’ and POB’ sequences. All the bacteriophage
nd site-specific recombinations, positive integrants are usually selected
ntains an antibiotic resistance marker.
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compatible integrative vector that allows the genomic
integration of BioBrick™ parts and can also be specialized
to target the desired integration site in the host genome by
using BioBrick™ parts. We also demonstrate the usefulness
of the designed tool by providing data on the modularity
of promoters when characterized in a single-copy context
and on plasmids.Figure 2 Integrative base vector pBBintФ structure. It is a chloramph
that impairs its replication in commonly used E. coli strains (without pir
conditional origin, so that they can be excised via Flp-mediated recomb
integrant without R6K. This vector targets the Ф80 attB site in the chrom
attP sequence is flanked by two NheI restriction sites to enable the eng
cloning site is flanked by BioBrick™ Prefix and Suffix sequences, while fo
when placed in the genome. Primer binding sites are also present. The
cassette, driven by the PR promoter. The glossary explains all the used s
this vector.Results and discussion
Design of the integrative base vector
Figure 2 shows the structure of the designed integrative
vector, pBBintФ. This base vector uses the default
integration guide Ф80 attP, although it can be specialized
according to user needs by changing guide and passenger.
The cloning site is compatible with the original BioBrick
standard (RFC10) and its related standards RFC23 andenicol-resistant vector with a conditional replication origin (R6K)
or pir-116 gene). Two FRT sites flank the resistance gene and the
ination once integrated in the genome, thus leaving a marker-less
osome of E. coli via the attP integration guide in the vector. The
ineering of this base vector by easily changing the guide. The
ur transcriptional terminators implement the insulation of the part
default insert of the vector is an mRFP1 constitutive expression
ymbols and lists the BioBrick™ basic parts used to compose
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and Suffix [17]. The presence of illegal restriction sites
(XbaI in FRT and SpeI in the Ф80 attP) prevents the
usage of this backbone in the classic BioBrick™ Standard
Assembly process. However, the presence of unique EcoRI
and PstI sites in Prefix and Suffix fully supports the
assembly of the desired BioBrick™ parts in the cloning
site upon EcoRI-PstI digestion and also supports the
3A Assembly [19,21] (see Figure 3A). The two NheI
restriction sites flanking the default integration guide
enable the engineering of this backbone by assembling
new user-defined BioBrick™ integration guides upon
XbaI-SpeI digestion, if the desired guide conforms to
the RFC10 or to a compatible standard (see Figure 3B).
Although such assembly is non-directional, integration
occurs regardless to guide orientation. Like in many
other standard vector backbones (e.g., the pSB**5 vector
series in the Registry of Standard Biological Parts [18]),
the binding sites for standard primers VF2 and VR are
present upstream and downstream of the BioBrick™ cloning
site respectively. These two sequences are sufficiently
distant from the cloning site to enable a good quality
sequencing of the insert. The R6K conditional replication
origin is necessary to avoid the extra-chromosomal
maintenance of the vector during integration; specific
strains with the pir or pir-116 genes are required to
propagate it during the cloning steps.
The four BioBrick™ transcriptional terminators BBa_
B0053, BBa_B0054, BBa_B0055 and BBa_B0062 ensure
the transcriptional insulation of the integrated part from
its flanking genome sequences, as it is achieved in
the pSB**5 vector series. The two FRT recombination
sites enable the excision of the R6K origin and the
chloramphenicol resistance marker upon Flp recombinase
activity. This marker excision allows users to make
multiple serial integrations in the same strain in different
target loci, always using the same antibiotic resistance
marker. The same FRT recombination procedure can also
be used, provided that essential chromosomal genes lie
between the different target loci (see [12] and [15] for a
detailed description of such potential problem when
multiple FRT sites are introduced in the same genome).
Additional details about vector sequence, features and
construction are available in the BBa_K300000 Registry
page.
The engineering of the integration guide allows the in-
tegration of parts in user-defined genome positions and
for this reason this vector supports the integration by
exploiting bacteriophage attP-mediated integration as
well as homologous recombination.
In this study, the default insert of pBBintФ is BBa_I763007,
a constitutive mRFP1 expression cassette driven by the PR
promoter from lambda phage. Note that an early version
of the integrative vector included a different default insertthat in our experience showed problems, as discussed in
Additional file 1: Additional information about integrative
base vector design.
Vector performance validation in the default integration
locus
The integration and marker excision capabilities of pBBintФ
were tested by integrating a number of BioBrick™
passengers in the chromosome of MG1655 and MC1061
strains. The integrative base vector targets the default
integration locus Ф80 attB.
Integration: 100% of the screened colonies (N = 39) on
the chloramphenicol plate lost the helper plasmid and
100% of the screened clones (N = 11) showed a correct in-
tegration position by PCR (see Additional file 1: Figure S1).
82% of the screened clones (N = 11) had at least two
tandem copies of the integrated DNA, as PCR showed
(see Additional file 1: Figure S2).
Marker excision: 100% of the screened colonies (N = 100)
lost the helper plasmid, while 68% of them had a successful
marker excision, validated via chloramphenicol sensitivity.
94% of the chloramphenicol-sensitive screened clones
(N = 33) also showed a correct amplicon (see Additional
file 1: Figure S3 for a representative experiment) by PCR
with primers P1-P4 (see Methods section), thus validating
the presence of the construct of desired size in the correct
genomic position. In this case, the multiple tandem copies,
previously identified by PCR, became a single copy
without antibiotic resistance or R6K origin. This tandem
copy loss happened because the Flp enzyme excised the
entire sequence flanked by the two most distal FRT
sites, thus generating a single integrant of the desired
construct.
100% of the screened clones with correct P1-P4 amplicon
(N = 12) showed the expected sequencing results. 83%
of them also showed the expected phenotype. Additional
file 1: Additional information about integrated BioBrick™
devices and phenotypes of recombinant strains reports the
full list of integrated BioBrick™ devices (Additional file 1:
Table S1) and additional information on integration
experiments.
Characterization of a set of BioBrick™ promoters in two
different genomic positions
A representative set of widely used BioBrick™ constitutive
promoters with the RBS-mRFP1-terminator sequence
downstream were integrated in the Ф80 or aspA genomic
locus and characterized. The considered BioBrick™ pro-
moters were BBa_J23100, BBa_J23101, BBa_J23118,
BBa_I14032 and BBa_R0051, indicated in this work as
J23100, J23101, J23118, PlacIQ and PR respectively, while
the downstream sequence was the BioBrick™ reporter de-
vice BBa_I13507. These constructs were also characterized
in the low copy vector pSB4C5, used as a term of
Figure 3 How to engineer the base vector. A) The desired BioBrick™ insert can be assembled as passenger in the integrative vector: the
BioBrick™ passenger of interest must be digested with EcoRI-PstI, while the integrative vector is also digested with EcoRI-PstI to eliminate the default
insert BBa_I763007. The two parts can be ligated and the product has to be transformed into a pir/pir-116 strain to enable the propagation of the
vector. B) The vector can be specialized with BioBrick™ parts to target the desired locus of the E. coli chromosome: the BioBrick™ guide of interest
must be digested with XbaI-SpeI, while the integrative vector must be digested with NheI to eliminate the default guide (Ф80 attP). The open vector
must be dephosphorylated to avoid self-ligation, the two parts can be ligated and the product has to be transformed into a pir/pir-116 strain. XbaI,
SpeI and NheI all have compatible protruding ends. Note that the ligation is not directional, but the guide can work in both directions. The guide can
be another attP site or a part which shows a significant homology with a genomic region of the host.
Zucca et al. Journal of Biological Engineering 2013, 7:12 Page 5 of 13
http://www.jbioleng.org/content/7/1/12
Figure 4 BioBrick™ promoters characterization, expressed in Relative Promoter Units, in single chromosomal copy (Ф80 and aspA loci)
and in low-copy context (pSB4C5 vector). Promoter activity was measured via the BBa_I13507 (RBS BBa_B0034-mRFP1-double terminator) part.
Grey bars represent the average values, computed on at least five clones, and the error bars represent the 95% confidence intervals. For each
promoter, statistical analysis was performed via ANOVA test to compare the RPU activities measured in the three different contexts. Conditions
showing a statistical difference (P < 0.05) in the mean activities among the three conditions are marked with a ‘+’ sign, while promoters not
showing any significant difference (P≥ 0.05) are marked with a ‘-’ sign. Asterisks represent the post-hoc comparison results. They indicate the
individual significantly different condition.
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characterized in different strains and conditions [22].
Figure 4 shows the RPU values of promoters measured
in the three different physical contexts. Given a promoter
and a physical context, the activity of the J23101 promoter
in the same context was used as a reference to compute
RPUs. While the activity of both J23100 and PR is not
statistically different when compared in the three contexts,
J23118 and PlacIQ activities show a significant difference
in one of the tested contexts with a CV of 20% and 31%
respectively. The activity of PlacIQ in plasmid contextFigure 5 BioBrick™ promoters characterization, expressed in absolute
Promoter activity was measured via the BBa_I13507 (RBS BBa_B0034-mRFP
computed on at least five clones, and the error bars represent the 95% con
via t-test to compare the activities measured in the two different contexts.
activities between the two conditions are marked with a ‘+’ sign, while pro
with a ‘-’ sign.is different from its activity in the chromosome. This
difference could be due to the sequence upstream of
the promoter that is identical for the two genomic
contexts, but it is different in the pSB4C5 vector which
could affect promoter activity [22,23]. The different up-
stream sequence is not sufficient to explain the difference
observed in the J23118 activity, where the promoter shows
the same activity in low copy vector and aspA locus, but a
slightly lower activity in the Ф80 locus.
Figure 5 shows the absolute promoter activities (Scell
value, see Methods section) in the two genomic loci. Theunits (Scell), in the two single-copy contexts (Ф80 and aspA loci).
1-double terminator) part. Grey bars represent the average values,
fidence intervals. For each promoter, statistical analysis was performed
Comparisons showing a statistical difference (P < 0.05) in the mean
moters not showing any significant difference (P≥ 0.05) are marked
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higher activity than in the Ф80 locus, although statistical
analysis showed only two promoters with a significant
activity difference. These results could be due to several
reasons, such as local sequence effects and distance
from the replication origin [24]. However, given the
complexity of the genome context, the investigation of
these effects is beyond the scope of this work.
Finally, the average estimated copy number of the low
copy vector is about 7 (measured by dividing the absolute
promoter activity in low copy by the one in single copy
number), which is consistent with the reported copy
number of the pSC101 origin [18,19] and also with previous
works [25,26].
Evolutionary stability of the integrated BioBrick™ devices
All the recombinant strains tested in the previous section
were also studied during continual bacterial growth
for 150 generations. Figure 6 shows the average percent
activity, relative to generation 0, of promoters over the
generations for each investigated condition: devices
integrated in the Ф80 or aspA locus or contained in a
low copy vector propagated with or without antibiotic.
Additional file 1: Figure S4 shows the results for each
individual promoter in the above mentioned conditions.
All the recombinant strains are reasonably stable after 150
generations, with only one of the J23100 samples in the
aspA locus showing a significant activity loss after >80
generations (see Additional file 1: Figure S4A). Surprisingly,
promoter activities are reasonably stable after 150 genera-
tions even in the low copy condition without antibiotic.
These results show that the majority of the population
of the integrated strains likely has not lost the desiredFigure 6 Evolutionary stability of the studied BioBrick™ promoters ex
were propagated without antibiotic, while the devices carried on the low-c
The four panels show the average percent activity of all the five studied pr
average activity at generation 0. For each time point, error bars represent tfunction and their stability is comparable with the low
copy plasmid condition.
In order to extend the characterization of the propagated
cultures, a second experiment was performed on inte-
grated strains and on plasmid-bearing strains grown in
presence of antibiotic, at generation 0 and 150. The fluor-
escence of single clones isolated from glycerol stocks of
150 generation-old cultures was measured to evaluate
fluorescence distribution in the population. Single
clones from the original glycerol stocks (generation 0)
were also assayed for each recombinant strain as a term
of comparison. Results are shown in Additional file 1:
Figure S5. According to these data and their interquartile
ranges (see Additional file 1: Table S2), the variability of
integrated strains at generation 150 is not significantly
different from the variability of the same cultures at
generation 0 (p > 0.05, Wilcoxon signed rank test). The
variability of fluorescence in plasmid-bearing strains is
lower than in integrated strains for both generation 0 and
150 (p < 0.05, Wilcoxon rank sum test). In accordance
with population-based experimental results, a large
portion of the clones bearing the J23100 construct
(culture 2) in the aspA locus lost their activity. Finally, the
averaged fluorescence of the single clones from evolved
cultures is highly consistent with the fluorescence of the
whole evolved populations, obtained by assaying a culture
propagated from glycerol stock (see Additional file 1:
Figure S6).Conclusions
Several methods have been proposed to target the desired
genetic construct into a specific chromosomal locus [27]pressing RFP. The devices integrated in the Ф80 (A) and aspA (B) loci
opy vector pSB4C5 were propagated without (C) or with (D) antibiotic.
omoters over time in each condition, where 100% represents the
he standard deviations of the measured values.
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focused on single-copy integrants generation [15], on the
elimination of antibiotic resistance [12,28] or on the copy
number amplification of the integrated device [29,30].
Although several genetic tools have been proposed in
literature to perform the tasks described above, no
plasmid-based standard tools are available to rapidly
construct a ready-to-integrate genetic system.
This work describes a BioBrick™ integrative base vector
for E. coli. Its standard physical interface allows the assembly
of the desired parts as passenger or integration guide,
both in BioBrick™ format. This vector is desirable to
rapidly disclose, via quantitative characterization, if the
parts under investigation are suitable in the genomic
context and, if required, in single-copy.
The design of this vector was inspired by previous works.
In particular, Shetty et al. [19] conceived a BioBrick™ base
vector that could be specialized to construct BioBrick™-
compatible vector backbones by using BioBrick™ parts as
well. For example, vectors with different replication
origins or antibiotic resistance markers could be easily
assembled from a standard ancestor. Before the work
of Shetty et al., the construction of vector backbones
required specific genetic manipulations whose knowledge is
normally owned by experts. On the other hand, Anderson
et al. [20] used BioBrick™ parts to construct different in-
tegrative vectors to produce methylase-expressing stable
strains without antibiotic resistance marker.
Our work merges such concepts by providing a ready-
to-engineer base vector containing all the required
features for integration (i.e., a conditional replication origin
and an antibiotic resistance marker), marker excision
(i.e., FRT sites flanking antibiotic marker and conditional
origin), assembly of BioBrick™ parts as passenger (i.e.,
BioBrick™ Prefix and Suffix) or guide (i.e., NheI sites
flanking the default guide). The structure of the vector
enables the integration of parts properly isolated from the
genomic context. In this way, all the integrated sequences
have the same upstream and downstream sequences.
Whatever the integration procedure is, the compatibility
of the vector with the target chassis always has to be
verified: the presence of the integration locus and,
when using site-specific recombination, the absence of
prophages in the attB locus must be evaluated according
to the declared genotype, genomic databases or by PCR.
While our aim was to provide a physical support to
standardize the integrative vector construction that can be
used with the desired integration procedure (site specific
or homologous recombination by single crossover), this
work is not intended to contribute novel integration
protocols or methodologies that improve its efficiency. In
fact, the efficiency depends on the specific guide, passenger
and protocol used. For example, in this work the Ф80
site-specific recombination had a very high success ratewhile the aspA homologous recombination showed a lower
efficiency (see Additional file 1: Additional information
about integrative vector efficiency).
A set of BioBrick™ devices, including widely used
constitutive promoters assembled with an RFP meas-
urement system, were used as passengers in most of
the integration experiments. The behaviour of these
devices was quantitatively characterized in single copy
in two different loci and in a low copy plasmid. The
measured promoter activities were consistent with
previous works [22,25]. Given a promoter, its relative
activity was comparable among the tested contexts, with a
maximum CV of 31% (PlacIQ promoter). Although the
different sequence between the upstream regions in the
single- and low-copy contexts could be responsible of this
activity variation in the case of PlacIQ, the sequence
difference could not explain all the observed variability
among the contexts. The detected variability entity was
consistent with our previous studies on context-dependent
variability of these promoters when tested via different
measurement systems or when assembled in different
genetic circuits [22].
The absolute activity of each integrated promoter was
also compared in the two chromosomal positions. Results
highlighted a promoter activity difference between the
aspA and the Ф80 loci, even if only two of the five
promoters showed a statistically significant difference.
Although a detailed investigation of such effects is beyond
the scope of this work, these results demonstrated the
importance of quantitative characterization of parts in
different genomic contexts for the predictable design of
genetic functions.
Finally, the stability of these integrated BioBrick™ devices
has been evaluated via population-based assays and via
variability analysis of individual clones. These experiments
demonstrated that many integrated strains had comparable
stability with plasmid-based ones, even though a small
subset of evolved integrated strains showed activity loss.
Analysis of the activity of individual clones at generation 0
and 150 showed that variability between the two genera-
tions was similar and that integrated strains had higher
variability when compared to plasmid-bearing strains. As
the used parts were not toxic or hard-to-express parts for
the chassis, these stability experiments only represented a
proof-of-concept, while the stability of parts has to be tested
for each desired construct in the future and it could be
dependent on the integration site, DNA sequence, host
organism, metabolic burden and/or specific function
implemented by the integrated device.
Methods
Strains and plasmids
All the E. coli strains used in this study are listed in
Table 1. MG1655 [31] and MC1061 [32] were used as
Table 1 Strains used in this study
Strain Relevant genotype Source
MG1655 wild-type K-12, no Φ80 prophage CGSC (#7740)
MC1061 no Φ80 prophage CGSC (#6649)
BW23474 recA1 endA9(del-ins)::FRT uidA4(del)::pir-116 CGSC (#7838)
TOP10 recA1 endA1 Invitrogen
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high copy number the plasmids with the R6K conditional
replication origin. TOP10 were heat-shock transformed
according to manufacturer’s protocol, while the other
strains were made chemically competent as described in
[33] and were heat-shock transformed at 42°C for 1 min.
Table 2 lists the plasmids used for the construction of
the integrative vectors and the used helper plasmids.
The genetic devices used for single copy and low copy
characterization of BioBrick™ parts have been reported
previously [22,25]. Briefly, all of them are composed by a
promoter (BBa_J23100, BBa_J23101, BBa_J23118, BBa_
I14032 or BBa_R0051) assembled to the RBS-mRFP1-
Terminator sequence (BBa_I13507 reporter device) via
BioBrick™ Standard Assembly [17]. For this reason,
DNA junctions between the two sequences are identical
(i.e. TACTAGAG) for all the constructs. Low copyTable 2 Plasmids used for integrative vector construction
Name BioBrick™ code Description
pHC-attP-CS pMK-RQ(BBa_K300983)a DNA fragment
high copy vec
pHC-CmR pSB1A1(BBa_P1004)b Chlorampheni
pHC-ter pSB1AK3(BBa_B0015)b Double termin
pHC-R6K pSB1A2(BBa_J61001)b R6K condition
pHC-CmRter pSB1AK3(BBa_K300032)c Chlorampheni
pHC-PR-RFP pSB1A2(BBa_I763007)b RFP constitutiv
pHC-CmRter-R6K pSB1A2(BBa_K300008)c Chlorampheni
pBBintФ-B0033 BBa_K300982c Integrative bas
pBBintФ-RFP BBa_K300000(BBa_I763007)c Integrative bas
cassette as ins
pHC-aspA pSB2K3(BBa_C0083)b aspA coding s





pCP20 not in the Registrye Ampicillin- and
sensitive pSC1
heat-sensitive
The BioBrick™ code of the plasmids include the vector name out of brackets and in
a: obtained from Mr. Gene DNA synthesis service. pMK-RQ is a kanamycin-resistant
b: obtained from DNA Distributions of the MIT Registry of Standard Biological Parts.
c: constructed in this study.
d: gift from the Dr. J.C. Anderson lab (UC Berkeley).
e: obtained from CGSC (plasmid purified from recombinant strain CGSC#7629).characterization was performed on the genetic devices in
the pSB4C5 BioBrick™ vector.
Cloning methods
Plasmids were propagated in recombinant strains grown
in selective Luria-broth (LB) [33] at 37°C, except
plasmids containing a temperature-sensitive replication
origin that were grown at 30°C. Antibiotics were routinely
used for plasmid maintenance during DNA propagation:
ampicillin (100 mg/l for high copy plasmids, 50 mg/l for
low copy plasmids), chloramphenicol (12.5 mg/l) and
kanamycin (50 mg/l). Liquid cultures (5 ml) were incubated
with shaking at 220 rpm. DNA was extracted with
the NucleoSpin Plasmid kit (Macherey-Nagel) from
recombinant cultures grown to saturation. Purified DNA
was digested as required and gel-extracted with the
NucleoSpin Extract II kit (Macherey-Nagel). DNA parts
were ligated to construct all the plasmids described in
this work. 1 μl of ligation mix was transformed into a
proper E. coli strain, DNA was purified and screened
via restriction digest and electrophoresis. Sequencing
was performed to validate all the plasmids with primers
VF2 (TGCCACCTGACGTCTAAGAA) and VR (ATTAC
CGCCTTTGAGTGAGC). Long-term bacterial stocks were
prepared by mixing 750 μl of a saturated culture with
250 μl of 80% glycerol and stored at −80°C.including FRT-NheI-attP-NheI-CS(B0033)-FRT, flanked by AvrII sites, in
tor
col resistance gene with promoter in high copy vector
ator in high copy vector
al replication origin in high copy vector
col resistance cassette in high copy vector
e expression cassette, driven by the PR promoter in high copy vector
col resistance cassette with R6K origin downstream in high copy vector
e vector, targeting the Ф80 locus, with RBS BBa_B0033 as insert
e vector, targeting the Ф80 locus, with RFP constitutive expression
ert
equence in high copy vector
tor, specialized to target the aspA locus, with RFP constitutive expression
ert
tant low copy helper plasmid, with temperature-sensitive pSC101 origin,
onstitutively expressed pir-116 gene and the site-specific recombination
he Ф80 phage under the control of a heat-sensitive promoter.
chloramphenicol-resistant low copy helper plasmid, with temperature-
01 origin, containing the yeast Flp recombinase under the control of a
promoter.
sert name in brackets.
high copy number delivery vector from Mr. Gene.
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Phosphatase is from New England Biolabs. Platinum Taq
DNA polymerase (Invitrogen) or Phusion Hot Start Flex
DNA Polymerase (New England Biolabs) were used to
perform PCR. All the other DNA-modifying enzymes
are from Roche Diagnostics. Enzymes have been used
according to manufacturer’s protocols. Oligonucleotides
were purchased from Primm (San Raffaele Biomedical
Science Park, Milan, Italy) or from Sigma Aldrich.
Sequencing was performed by BMR Genomics (Padua,
Italy) DNA analysis service.
Integrative base vector construction procedure
Additional file 1: Figure S7 shows the assembly scheme
followed to construct the pBBintФ vector backbone. Briefly,
pHC-CmRter was constructed via BioBrick™ Standard
Assembly by assembling the insert of pHC-CmR, digested
with EcoRI-SpeI, to pHC-ter digested with EcoRI-XbaI.
Analogously, pHC-CmRter-R6K was obtained by assem-
bling the insert of pHC-CmRter, digested with EcoRI-SpeI,
to pHC-R6K digested with EcoRI-XbaI. The insert of
pHC-attP-CS is composed by, in this order, FRT-NheI-attP-
NheI-CS(BBa_B0033)-FRT, where CS is a cloning site
composed by EcoRI and PstI with four transcriptional
terminators flanking them and two standard primer
binding sites for VF2 and VR (see Figure 2). In this plasmid,
the CS contains the small BioBrick™ RBS BBa_B0033
between EcoRI and PstI. The insert of pHC-attP-CS was
excised through digestion with AvrII and it was assembled
with the insert of pHC-CmRter-R6K, which had been
excised from its vector through digestion with XbaI-SpeI
and dephosphorylated, to obtain pBBintФ-B0033.
Finally, pBBintФ-RFP was obtained by assembling the
insert of pHC-PR-RFP, digested with EcoRI-PstI, to
the vector backbone of pBBintФ-B0033, digested
with EcoRI-PstI in order to cut out and eliminate the
BBa_B0033 RBS.
Assembly of the desired passenger and guide
The source or assembly procedure of all the BioBrick™
constructs used as passengers has been reported previ-
ously [22,25]. These constructs have been excised from
their original vector backbone upon EcoRI-PstI double
digest and they have been cloned into the pBBintФ or
pBBintAsp vector as described in Figure 3A.
The aspA coding sequence, used as DNA guide for
homologous recombination, was excised from its original
vector backbone upon XbaI-SpeI double digest and it has
been cloned into the pBBintФ-RFP plasmid, digested with
NheI, as described in Figure 3B, and dephosphorylated.
Chromosomal integration
The protocol described in [20] was used for site-specific
recombination. Briefly, competent cells were transformedwith the pInt80-649 helper plasmid [20]. Transformants
were grown at 30°C and were made competent again.
They were transformed with the pBBintФ integrative
vector containing the part of interest as passenger and
were grown on chloramphenicol plates at 30°C until
colonies appeared. A single colony was propagated in
LB with chloramphenicol at 37°C, 220 rpm overnight.
The culture was streaked on a chloramphenicol plate
and incubated overnight at 43°C. A single colony was
grown in LB + chloramphenicol to yield the integrant
strain. This colony was also streaked on an ampicillin
plate to validate the loss of pInt80-649. Colony PCR was
occasionally performed with primers P1 (CTGCTTGT
GGTGGTGAAT) [15] and P2 (CTCTTACGTGCCCGA
TCA), which anneal upstream of the Ф80 chromosomal
attB site and in the R6K origin respectively. The P1-P2
amplicon (452 bp) indicates the correct integration
position, as described in [15], while negative clones
show no amplicon. It is also possible to identify clones
with multiple tandem copies of the integrated part via
colony PCR with primers P2 (described above) and P3
(AGACGTCAGGTGGCAAAC), which anneal in opposite
directions in the R6K origin and in the upstream region of
the cloning site. PCR yields a 572-bp amplicon when at
least two tandem copies are present in the genome, while
no amplicon is produced otherwise.
If not differently stated, the chloramphenicol concentra-
tion used in all the steps of the site-specific recombination
was 12.5 mg/l.
An analogous protocol was used for homologous
recombination, with the exception that the passenger was
present in the pBBintAsp vector and the chloramphenicol
concentration used was 8 mg/l. In this case, the pInt80-649
plasmid was used to replicate the integrative plasmid
via the pir-116 gene, while the Ф80 site-specific
recombination machinery was not exploited, although it
was expressed during the protocol.
Other integration protocols were tested (see Additional
file 1: Additional integration protocols and their relative
results).
Excision of antibiotic resistance and R6K origin from an
integrant strain
The protocol described in [20] was used. Briefly, the
integrant strain was grown in LB and made competent.
This strain was transformed with the pCP20 helper
plasmid [16], plated on ampicillin plates and incubated
at 30°C until colonies appeared. A single colony was
propagated in non-selective LB at 37°C, 220 rpm overnight.
The culture was streaked on a non-selective plate and
incubated at 43°C. A single colony was propagated in
non-selective LB to obtain the final single-copy integrant
strain without the chloramphenicol resistance marker and
the R6K origin. The loss of the antibiotic marker and
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obtained strain on chloramphenicol and ampicillin
plates respectively. The obtained integrant strain was
also assayed through colony PCR with primer pair P1
(reported above) and P4 (CTCTTACGTGCCCGATCA)
for Ф80 attB targeting and with primer pair AspAFw
(TGCGAGGATCGTGATGTATTTCGG) and AspARv
(ATGATCTCGGGTATTCGGTCGATG) for aspA targeting.
PCR products were also purified with the NucleoSpin
Extract II kit and sequenced with the previously reported
primer pairs or with VF2 and VR.
Characterization of promoters
MG1655 was used as chassis for the quantitative experi-
ments. 1 ml of M9 supplemented medium (11.28 g/L M9
salts, 1 mM thiamine hydrochloride, 2 mM MgSO4,
0.1 mM CaCl2, 0.2% casamino acids and 0.4% glycerol as
carbon source) [33] was inoculated with a single colony of
the desired recombinant strain, grown on a streaked
LB agar plate. The culture, in a 15-ml tube, was incubated
at 37°C, 220 rpm for about 20 hours and then it was
500-fold diluted in 1 ml and incubated in the same
conditions as before for 6 hours. 200 μl were transferred
into a 96-well microplate (Greiner), the optical density at
600 nm (OD600) was measured with an Infinite F200
microplate reader (Tecan) and the background absorbance
of the medium was subtracted. The culture was diluted to
an OD600 of 0.05 (pathlength of the culture volume in
the microplate) in 0.5 ml and it was incubated again for
45 min. 200 μl were transferred into a 96-well microplate,
incubated at 37°C for 10–15 hours in the Infinite F200
and assayed via the following kinetic cycle, programmed
with the i-control™ software (Tecan): linear shaking (3 mm
amplitude) for 15 s, wait for 10 s, OD600 measurement,
fluorescence measurement (excitation: 535 nm; emission:
625 nm; gain: 80), sampling time: 5 min. Sterile medium
and a non-fluorescent culture of MG1655 were always
present in order to measure the background absorbance
and fluorescence. This procedure was repeated for at least
five different colonies from the freshly streaked plate for
each recombinant strain.
Integrant strains were tested without antibiotic, while
the plasmid-bearing strains were tested in presence of
12.5 mg/l of chloramphenicol. When required, analogous
procedures were performed to test recombinant MC1061
strains.
Data analysis for promoter activity measurement
Data were analyzed with Microsoft Excel and the MATLAB
2007b suite (MathWorks, Natick, MA). Raw absorbance
and fluorescence time series were processed as previously
reported [22,25,34] to obtain a value proportional to the
average RFP synthesis rate per cell in exponential phase
(called Scell).Relative Promoter Units (RPUs) were obtained as
described previously [22,25,34], by dividing the Scell of
the promoter of interest, in a given copy number condition,
by the Scell of the J23101 standard reference promoter in
the same copy number condition. By definition, the RPU
of the J23101 promoter is 1 in all the copy number condi-
tions. Given a physical context, (i.e. the Ф80 locus, the
aspA locus or the pSB4C5 vector), the genetic device
should be present at the same copy number for all the
tested promoters, as the integrated strains after marker/
R6K excision have a single genomic copy of the BioBrick™
passenger in the target locus and the strains with low copy
plasmid should maintain the device at the same copy
number because all the plasmids are equal except the
promoter to be measured. All the devices should produce
the same mRNA sequence, as the predicted transcription
start site is very similar for all the promoters ([34,35]) and
the sequence downstream of the promoters is exactly the
same (BBa_I13507). Finally, given a physical context, the
growth rate of strains bearing a promoter of interest was
similar to the growth rate of the strain bearing the
BBa_J23101 reference promoter (data not shown). For
these reasons, the RPU approach can be applied to
characterize the promoters of interest of this work, as the
validity hypotheses of the RPU approach are assumed to
be respected.
All the coefficients of variation (CVs) were corrected for
small samples by multiplying them by the (1 + 1/(4 N))
factor, where N is the number of samples. Hypothesis tests
were performed via MATLAB.
When assessing the statistical difference among the
mean values of a group composed by more than two
samples, ANOVA was performed. If the test showed a
significant difference, post-hoc comparisons with the
Bonferroni correction were performed via individual
t-tests to compare the mean values.
In order to compute the CV within a group, the
non-significantly different values were averaged and
the final CV was computed on the mean values of the
statistically different sub-groups.Evolutionary stability experiments
Two 2-ml tubes with 1 ml of M9 supplemented medium
were inoculated with two single colonies from a freshly
streaked LB agar plate and they were incubated as
described above for 24 hours. Every 24 hours, the cultures
grown to saturation were 1000-fold diluted in 1 ml of sterile
medium and incubated under the same conditions as
before, in order to achieve ~10 generations per day
[36-38]. Every day, 1 μl of each saturated culture was
also added to 200 μl of sterile medium, incubated in the
Infinite F200 reader and assayed as described above. Data
were analyzed as before to obtain Scell. The activity of a
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activity at generation 0 (i.e. the first point of the time series).
Integrant strains were propagated and tested without
antibiotic. Plasmid-bearing strains were propagated and
tested in presence of 12.5 mg/l of chloramphenicol at
generation 0, while they were tested with and without
antibiotic for the following generations.
A freshly-inoculated non-fluorescent culture of MG1655
was always included in order to perform the fluorescence
background subtraction.
After 150 generations, a glycerol stock was prepared
for each evolved culture by mixing 750 μl of culture with
250 μl of 80% glycerol and stocks were long-term stored
at −80°C. Evolved cultures of integrant strains and
plasmid-bearing strains propagated with antibiotic were
streaked on LB or LB + chloramphenicol agar plates,
respectively. Plates were incubated at 37°C for about
20 hours. For each culture, 28 single colonies were
picked, 1 ml of M9 supplemented medium (without
antibiotic for integrant strains, with chloramphenicol for
plasmid-bearing strains) was inoculated in 2-ml tubes
and incubated at 37°C, 220 rpm for about 20 hours.
Grown cultures were then assayed and data analyzed
as described above. For each culture, 1 ml of M9
supplemented medium was also inoculated with 1 μl of
glycerol stock of generation 150 and then the culture was
incubated, assayed and analyzed as described above, to
perform the fluorescence measurement of the whole
evolved population (measured in duplicate).
Individual colonies isolated from non-evolved cultures
were also assayed as a term of comparison for each
recombinant strain. In this case 28 colonies were isolated
by streaking the original glycerol stocks of these strains on
LB agar plate.
For each culture, Scell data were normalized by the
median of the same recombinant strain at generation 0.
Interquartile range (IQR) was used to express the variability
of clones in each culture. Wilcoxon signed rank test was
used to compare variability between generation 0 and 150
for all the cultures (paired samples). Wilcoxon rank sum
test was used to compare variability between integrated
strains and plasmid-bearing strains (unpaired samples).Endnotes
1 BioBrick™ is a trademark of The BioBricks Foundation.
(http://www.biobricks.org).Additional file
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